PLANO, Texas--(BUSINESS WIRE)--April 10, 2006--Sigma Global Corporation (Pink Sheets:SGGC - News), today announced that it has expanded its product offering to include over 2,000 different generic and branded drugs and a full line of diabetes and respiratory medical supplies. The additional products and supplies will allow the Company to provide integrated medical solutions to its patients, an important competitive advantage for Sigma Global Corp. It will also generate significant operating cost savings for the Company.
